Investors / United States / Vivo Capital
Vivo Capital
Venture capital · Palo Alto, CA, United States · North America
Vivo Capital is a global healthcare investment platform with venture capital, private equity and public equity strategies. It has invested in over 460 healthcare companies and supports portfolio companies through its network of operating executives, industry partners and advisors.
Invests inHealthcare & Biotech
In its own wordshealthcarebiotechnologypharmaceuticalslife sciencesventure capitalprivate equity
Your fit with Vivo Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsVivo Capital lists 84 checked portfolio companies on its own site and is named in 15 funding rounds, 2 of them as lead. Its most frequent entry is Growth, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (95%), AI & Machine Learning (4%) and Legal & Compliance (1%). 63% of its companies are based in United States. It invests most often alongside RA Capital, Foresite Capital and venBio.
Counts come from funding rounds that name Vivo Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Vivo Capital's whole history. Rounds on record name 15 companies; its own site lists 84. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 8% |
| Series A | 8% |
| Series B | 33% |
| Growth | 50% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 1 | 0 |
| '25 | 0 | 0 |
| '26 | 14 | 2 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 93th | 83 companies |
| Recent activity | 97th | 13 rounds in 12 months |
| Early stage | 54th | 8% of entries at pre-seed or seed |
| Evidence | 67th | 6% of companies confirmed by a round |
| Sector focus | 97th | 95% in its largest sector |
| Reach | 97th | 12 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| RA Capital | 14 |
| Foresite Capital | 6 |
| venBio | 6 |
| Samsara BioCapital | 5 |
| TCG Crossover | 5 |
| Aisling Capital | 4 |
| Avoro Capital Advisors | 4 |
| Catalio Capital Management | 4 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers7589%
- No longer answers00%
- Points to another company911%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 95% | 15% |
| AI & Machine Learning | 4% | 18% |
| Legal & Compliance | 1% | 2% |
Co-investor network
who it backs companies with, and who they back togetherCompare Vivo Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Vivo Capital| Date | Company | Stage |
|---|---|---|
| 13 Nov 2026 | Series B | |
| 29 Sept 2026 | Series C+ | |
| 5 Aug 2026 | Series B | |
| 23 Jun 2026 | Series A | |
| 10 Jun 2026 | Seed | |
| 10 Jun 2026 | Series B | |
| 19 May 2026 | Series C+ | |
| 18 May 2026 | Series C+ Led |
Round details for Vivo Capital
Amounts, full round histories and every co-investor in Vivo Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
84 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
| Achieve Life Sciences is a late-stage specialty pharmaceutical company dedicated to tackling the global nicotine dependence epidemic by advancing cytisinicline. | Healthcare & Biotech | Portfolio page | ||
| Adarx Pharmaceuticals is developing next-generation siRNA therapeutics to treat various diseases. | Healthcare & Biotech | Portfolio page | ||
| Adaxion Therapeutics is advancing biologics deimmunized with their ADAx platform to overcome immunogenicity limitations in biologic therapies | Healthcare & Biotech | Portfolio page | ||
| Aerobiotix develops and provides surgical air purification and disinfection systems | Healthcare & Biotech | Portfolio page | ||
| Agno Pharma offers pharmaceutical development and manufacturing services | Healthcare & Biotech | Portfolio page | ||
| AkiraBio develops innovative and accessible therapies that improve the lives of people living with sickle cell disease and other hemoglobinopathies | Healthcare & Biotech | Portfolio page | ||
| Alto Neuroscience develops biology-driven medicines for neuropsychiatric conditions | Healthcare & Biotech | Portfolio page | ||
| AN2 Therapeutics develops boron-based medicines for various diseases, including polycythemia vera, Chagas disease, and certain types of cancer. | Healthcare & Biotech | Mar 2026Round | Funding round | |
| Ascendis Pharma is a biopharmaceutical company that develops new therapies using its TransCon technology platform to improve treatment safety, efficacy, tolerability, and convenience. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| BlossomHill Therapeutics designs and develops innovative small molecules to overcome the limitations of existing cancer therapies. | Healthcare & Biotech | Portfolio page | ||
| BioDlink provides CDMO solutions and services for pharmaceutical development and manufacturing | Healthcare & Biotech | Portfolio page | ||
| Bolt Biotherapeutics develops treatments for cancer | Healthcare & Biotech | Portfolio page | ||
| The company develops high-precision and personalized medical solutions and equipment to improve global medical quality, with a focus on male infertility and reproductive health. | Healthcare & Biotech | Portfolio page | ||
| Bonum Therapeutics uses a novel, antibody-based mechanism to create regulated and targeted medicines | Healthcare & Biotech | Portfolio page | ||
| Boundless Bio develops therapies for patients with intractable oncogene amplified cancers. | Healthcare & Biotech | Jun 2026Series A | Funding round | |
| Caidya provides clinical development services for various therapeutic areas | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Clasp Therapeutics is dedicated to transforming the lives of patients everywhere by mastering the discovery, development and delivery of off-the-shelf precision immunotherapies | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- vivocapital.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 13 May 2024
- Companies checked
- 84
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Vivo Capital's profile as data
Pull Vivo Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/vivocapital.com
# also
GET /v1/firms/vivocapital.com/portfolio
GET /v1/firms/vivocapital.com/coinvestors
GET /v1/firms/vivocapital.com/news